loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 21906 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ABBVIE (2)

filter

01 TABLET;ORAL (2)

filter

01 RX (2)

filter

01 KALETRA (2)

filter

01 Yes (2)

URL Supplier Web Content
TABLET; ORAL
200MG;50MG
2005-10-28
21906
KALETRA
RX
Yes
AB
Abbvie Company Banner

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
100MG;25MG
2007-11-09
21906
KALETRA
RX
Yes
AB
Abbvie Company Banner

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier

Looking for FDA Orange Book APPLICATION 21906

Looking for FDA Orange Book APPLICATION 21906 2

19

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LOPINAVIR; RITONAVIR, with a corresponding application number 21906.

Regulatory Information RX

With a dosage strength 200MG;50MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2005-10-28

Therapeutic Equivalence (TE) Code AB

18

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LOPINAVIR; RITONAVIR, with a corresponding application number 21906.

Regulatory Information RX

With a dosage strength 100MG;25MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2007-11-09

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY